Public Citizen

Public Citizen is a national, nonprofit consumer advocacy organization founded in 1971 to represent consumer interests in Congress, the executive branch and the courts.

Releases by this organization

Newswire article
Thursday, May 14, 2020
New Climate Policy Platform Centers on Social and Worker Justice
Members of the U.S. Climate Action Network (USCAN), a network of more than 175 U.S. organizations, today announced the Vision for Equitable Climate Action, a new policy platform that is necessary to combat the climate crisis effectively while advancing justice for workers and frontline communities...
Read more
Newswire article
Thursday, May 14, 2020
Public Health School Deans, Public Citizen Demand Congress Push Widespread COVID-19 Testing, Tracing
Congress must pass legislation that requires the Trump administration to use the Defense Production Act to produce sufficient COVID-19 tests, Public Citizen and four public health school deans said today. The legislation also should provide funding for a substantially expanded program of testing...
Read more
Newswire article
Wednesday, May 13, 2020
Reeling From Controversy, Facebook Launches Faceless Lobbying Group to Influence Congress, Regulators
Note: Facebook is launching a new lobbying group, American Edge, to fight lawmakers and regulators who are trying to rein in the tech industry. The group will not be required to disclose its donors. It’s no surprise that Facebook wants to go faceless. The company’s reputation around the country and...
Read more
Newswire article
Tuesday, May 12, 2020
HEROES Act Goes Big Just When It’s Needed
Note: U.S. House Speaker Nancy Pelosi (D-Calif.) today released the House Democrats’ $3 trillion HEROES Act, legislation in response to the ongoing coronavirus pandemic, including $3.6 billion in election security funding, $4.6 billion for a public health fund, $75 billion for coronavirus testing...
Read more
Newswire article
Tuesday, May 05, 2020
FDA: Release Research Data on Remdesivir for Emergency Use for Coronavirus Patients
The U.S. Food and Drug Administration should promptly release all research data supporting Gilead Sciences’ request for emergency use of remdesivir for treatment of patients hospitalized with the coronavirus infection (COVID-19), Public Citizen said today in a Freedom of Information Act (FOIA)...
Read more
Newswire article
Monday, May 04, 2020
Gilead Should Price Remdesivir at $1 Per Day
The Institute for Clinical and Economic Review (ICER) Friday announced two pricing models for remdesivir, marketed by Gilead Sciences as a treatment for COVID-19. While ICER’s cost effectiveness model suggests a price of $4500, the cost recovery model suggests a price of $1 per day. Researchers at...
Read more
Newswire article
Friday, May 01, 2020
Medicare Crisis Program: We Need Immediate Action Now
Note: U.S. Reps. Pramila Jayapal (D-Wash.) and Joe Kennedy (D-Mass.) today unveiled the Medicare Crisis Program Proposal, which would expand Medicare to Americans who lose their jobs due to the pandemic. It also would expand Medicaid eligibility. Just when we need it the most, America’s for-profit...
Read more
Newswire article
Thursday, April 30, 2020
The Federal Reserve Should Not Bail Out the Failing Fracking Industry
Note: The Federal Reserve today unveiled an expanded “Main Street” business lending program that could allow failing, highly indebted oil and gas companies to borrow money at low rates. In doing so, the Fed heeded a call by U.S. Sen. Ted Cruz (R-Texas) as well as fracking companies to make it...
Read more
Newswire article
Wednesday, April 29, 2020
USTR’s Adding Amazon Websites to ‘Notorious’ Markets List Is Terrific, but President Won’t Exercise Existing Authority to Close Loopholes Allowing Dangerous Goods to Flood U.S. Via Online Platforms
Note: Today, the Trump administration published it annual “Review of Notorious Markets for Counterfeiting and Piracy.” Several Amazon websites were added to the “Notorious” list. Public Citizen has called for the president to exercise his existing authority to close a loophole, called the de...
Read more
Newswire article
Monday, April 27, 2020
Now Is Not the Time to Price Gouge, Big Pharma
As the coronavirus pandemic continues to cost many Americans their jobs and health insurance, Big Pharma should commit not to increase the price of any medications, Public Citizen said today in letters to 20 major prescription drug corporations. Three in 10 Americans already were rationing their...
Read more

Pages